Status:
RECRUITING
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Texas Heart Institute
Conditions:
Heart; Dysfunction Postoperative, Cardiac Surgery
Genetic Predisposition to Disease
Eligibility:
All Genders
20-90 years
Brief Summary
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart ...
Detailed Description
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition, we also examin...
Eligibility Criteria
Inclusion
- Undergoing heart surgery
- Willing to provide consent
Exclusion
- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Key Trial Info
Start Date :
August 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2030
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT01258231
Start Date
August 1 2000
End Date
August 1 2030
Last Update
August 22 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
UT Southwestern Medical Center
Dallas, Texas, United States, 75390-9068
3
Department Texas Heart Institute at St. Luke's Episcopal Hospital
Houston, Texas, United States, 77225